{"id":198371,"date":"2024-10-19T12:37:42","date_gmt":"2024-10-19T12:37:42","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/aami-ul2800-1-2019\/"},"modified":"2024-10-25T05:10:45","modified_gmt":"2024-10-25T05:10:45","slug":"aami-ul2800-1-2019","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/aami\/aami-ul2800-1-2019\/","title":{"rendered":"AAMI\/UL2800 1 2019"},"content":{"rendered":"
Specifies a baseline set of requirements for assuring safe and secure interoperability for Interoperable Medical Systems.<\/p>\n
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
1<\/td>\n | ANSI\/AAMI\/UL 2800-1:2019; Standard for Safety for Medical Device Interoperability <\/td>\n<\/tr>\n | ||||||
2<\/td>\n | Objectives and uses of AAMI standards and recommended practices <\/td>\n<\/tr>\n | ||||||
3<\/td>\n | Title page <\/td>\n<\/tr>\n | ||||||
4<\/td>\n | Commitment for Amendments Copyright information <\/td>\n<\/tr>\n | ||||||
5<\/td>\n | Contents <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | Committee representation <\/td>\n<\/tr>\n | ||||||
10<\/td>\n | AAMI Standard <\/td>\n<\/tr>\n | ||||||
11<\/td>\n | 1 Introduction <\/td>\n<\/tr>\n | ||||||
12<\/td>\n | 2 Scope 3 References <\/td>\n<\/tr>\n | ||||||
13<\/td>\n | 4 Terms and Definitions <\/td>\n<\/tr>\n | ||||||
26<\/td>\n | 5 (Leadership) Management Responsibility <\/td>\n<\/tr>\n | ||||||
27<\/td>\n | 6 Interoperability Information <\/td>\n<\/tr>\n | ||||||
29<\/td>\n | 7 Interoperability Management <\/td>\n<\/tr>\n | ||||||
30<\/td>\n | Figure 7.1 INTEROPERABLE ENVIRONMENT ontology <\/td>\n<\/tr>\n | ||||||
31<\/td>\n | Figure 7.2 Schematic of interoperability realization lifecycle <\/td>\n<\/tr>\n | ||||||
32<\/td>\n | 8 Interoperability Realization Processes <\/td>\n<\/tr>\n | ||||||
41<\/td>\n | 9 Design, Development and Implementation of Interoperability <\/td>\n<\/tr>\n | ||||||
42<\/td>\n | Figure 9.1 Interoperability contexts of use <\/td>\n<\/tr>\n | ||||||
49<\/td>\n | 10 Interoperability of EXTERNALLY SOURCED PRODUCTS <\/td>\n<\/tr>\n | ||||||
51<\/td>\n | 11 Provisioning, Deployment, and Operation <\/td>\n<\/tr>\n | ||||||
52<\/td>\n | 12 Testing and Review <\/td>\n<\/tr>\n | ||||||
54<\/td>\n | 13 Traceability and Release <\/td>\n<\/tr>\n | ||||||
55<\/td>\n | 14 Interoperability Performance Monitoring and Control of Changes <\/td>\n<\/tr>\n | ||||||
57<\/td>\n | 15 Improvement of Processes <\/td>\n<\/tr>\n | ||||||
58<\/td>\n | Annex A (Informative) Stakeholder Activities <\/td>\n<\/tr>\n | ||||||
64<\/td>\n | Annex B (Informative) Guidance on Declaration of Products and Services Figure B1.1 Elements of interoperability ecosystem and key processes <\/td>\n<\/tr>\n | ||||||
65<\/td>\n | Figure B1.2 Primary compliance relationships <\/td>\n<\/tr>\n | ||||||
66<\/td>\n | Figure B1.3 Compliance relationships for primary topology categories <\/td>\n<\/tr>\n | ||||||
69<\/td>\n | Annex C (Informative) Guidance on INTEROPERABILITY FILE <\/td>\n<\/tr>\n | ||||||
70<\/td>\n | Table C1.1Work products <\/td>\n<\/tr>\n | ||||||
84<\/td>\n | Annex D (Informative) Guidance on DISCLOSURE <\/td>\n<\/tr>\n | ||||||
85<\/td>\n | Table D1.1 Disclosures <\/td>\n<\/tr>\n | ||||||
86<\/td>\n | Annex E (Normative) Interoperability Realization Life-cycle ProcessE1 <\/td>\n<\/tr>\n | ||||||
108<\/td>\n | Annex F (Informative) GUIDANCE ON RELEASE CRITERIA <\/td>\n<\/tr>\n | ||||||
112<\/td>\n | Annex G (Informative) Testing Guidance <\/td>\n<\/tr>\n | ||||||
118<\/td>\n | Annex H (Informative) RISK MANAGEMENT Guidance <\/td>\n<\/tr>\n | ||||||
124<\/td>\n | Annex I (Informative) Common Fault Types <\/td>\n<\/tr>\n | ||||||
125<\/td>\n | Annex J (Informative) Interoperability Usability Concepts <\/td>\n<\/tr>\n | ||||||
128<\/td>\n | Annex K (Informative) SECURITY Principles <\/td>\n<\/tr>\n | ||||||
130<\/td>\n | Annex L (Informative) Clinical Context Concepts <\/td>\n<\/tr>\n | ||||||
133<\/td>\n | Annex M (Informative) Clinical Properties of INTEROPERABLE MEDICAL SYSTEMS <\/td>\n<\/tr>\n | ||||||
152<\/td>\n | Annex N (Informative) Architecture Definition Guidance <\/td>\n<\/tr>\n | ||||||
153<\/td>\n | Figure N1 Entity\/relation diagram capturing the relationships between interoperable item, interoperablemedical system, item interoperability specification, interaction point, interoperable item boundary,and interoperability interface <\/td>\n<\/tr>\n | ||||||
155<\/td>\n | Figure N2 Diagram capturing the relationships between interoperability architecture, variability,interoperability architecture configuration, and interoperability architecture instance <\/td>\n<\/tr>\n | ||||||
162<\/td>\n | Annex O (Informative) INTEROPERABILITY ARCHITECTURE SPECIFICATION <\/td>\n<\/tr>\n | ||||||
167<\/td>\n | Annex P (Informative) Engineering Properties of INTEROPERABLE MEDICAL SYSTEMS <\/td>\n<\/tr>\n | ||||||
177<\/td>\n | Annex Q (Informative) Services for INTEROPERABLE MEDICAL SYSTEMS <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" ANSI\/AAMI\/UL 2800-1:2019 – Standard for Safety for Medical Device Interoperability<\/b><\/p>\n |